0001654706-15-000003.txt : 20151002 0001654706-15-000003.hdr.sgml : 20151002 20151002134355 ACCESSION NUMBER: 0001654706-15-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20151002 DATE AS OF CHANGE: 20151002 EFFECTIVENESS DATE: 20151002 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Antegrin Therapeutics, Inc. CENTRAL INDEX KEY: 0001654706 IRS NUMBER: 473395909 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-248662 FILM NUMBER: 151139558 BUSINESS ADDRESS: STREET 1: 4320 FOREST PARK AVENUE STREET 2: SUITE 303 CITY: ST. LOUIS STATE: MO ZIP: 63108 BUSINESS PHONE: 314-882-6886 MAIL ADDRESS: STREET 1: 4320 FOREST PARK AVENUE STREET 2: SUITE 303 CITY: ST. LOUIS STATE: MO ZIP: 63108 D 1 primary_doc.xml X0707 D LIVE 0001654706 Antegrin Therapeutics, Inc. 4320 FOREST PARK AVENUE SUITE 303 ST. LOUIS MO MISSOURI 63108 314-932-4032 x317 DELAWARE None None Corporation true 2014 Charles Bolten 4320 Forest Park Avenue Suite 303 St. Louis MO MISSOURI 63108 Director Thomas P. Cirrito 4320 Forest Park Avenue Suite 303 St. Louis MO MISSOURI 63108 Director Rajesh Devraj 4320 Forest Park Avenue Suite 303 St. Louis MO MISSOURI 63108 Director David W. Griggs 4320 Forest Park Avenue Suite 303 St. Louis MO MISSOURI 63108 Director Robert W. Karr 4320 Forest Park Avenue Suite 303 St. Louis MO MISSOURI 63108 Executive Officer Director George H. Capps, II 4320 Forest Park Avenue Suite 303 St. Louis MO MISSOURI 63108 Executive Officer Michael A. Yeadon 4320 Forest Park Avenue Suite 303 St. Louis MO MISSOURI 63108 Director Pharmaceuticals Decline to Disclose 06c false 2015-09-17 false true false 1 600000 100000 500000 false 1 0 0 0 false Antegrin Therapeutics, Inc. /s/ Robert W. Karr Robert W. Karr President and CEO 2015-10-02